148
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural Hematoma

ORCID Icon, , , , , , , , & show all
Pages 943-948 | Published online: 09 Apr 2020

References

  • Xu F. The research progress of traumatic subdural effusion. Int J Neurol Neurosurg. 2011;38:182–185.
  • John JN, Dila C. Traumatic subdural hydroma in adults. Neurosurgery. 1981;9:621–625.7322326
  • Liu YG, Jia T, Liu M. Typing and clinical characteristics of traumatic subdural effusion. Chi J Surg. 2003;41(10):763–765.
  • Liu YG, Zhu SG, Jiang YQ. Evolution of traumatic subdural hydroma into chronic subdural hematoma. Chi J Surg. 2002;40(5):360–362.
  • Cao DM, Qi WT, Wu YK. Atorvastatin clinical study on reducing the conversion of traumatic subdural effusion into chronic subdural hematoma. Chi J Crit Care Med (Electronic Edition). 2018;11(3):197–199.
  • Yamada H, Nihei H, Watanabe T, et al. Chronic subdural hematoma occurring consequently to the posttraumatic subdural hygroma–on the pathogenesis of the chronic subdural hematoma (author’s transl). No To Shinkei. 1979;31(2):115–121.426938
  • Ohno K, Suzuki R, Masaoka H, et al. Role of traumatic subdural fluid collection in developing process of chronic subdural hematoma. Bull Tokyo Med Dent Univ. 1986;33(3):99–106.3471365
  • Lee KS, Bae WK, Park YT, et al. The pathogenesis and fate of traumatic subdural hygroma. Br J Neurosurg. 1994;8(5):551–558. doi:10.3109/026886994090029477857535
  • Wang Y, Wang C, Liu Y. Chronic subdural haematoma evolving from traumatic subdural hydroma. Brain Inj. 2015;29(4):462–465. doi:10.3109/02699052.2014.99051325536390
  • Feng JF, Jiang JY, Bao YH, et al. Traumatic subdural effusion evolves into chronic subdural hematoma: two stages of the same inflammatory reaction? Med Hypotheses. 2008;70:1147–1149. doi:10.1016/j.mehy.2007.11.01418248915
  • Xu GS, Li MH, Li YY, et al. Subdural effusion is the basis of chronic subdural hematoma formation foundation. Jiangxi Med J. 2010;45:114–116.
  • Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes including amyloid beta. Sci Transl Med. 2012;4(147):147ra111. doi:10.1126/scitranslmed.3003748
  • Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner’s guide. Neurochem Res. 2015;40(12):2583–2599. doi:10.1007/s11064-015-1581-625947369
  • Iliff JJ, Chen MJ, Plog BA, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci. 2014;34(49):16180–16193. doi:10.1523/JNEUROSCI.3020-14.201425471560
  • Gaberal T, Gakuba C, Goulay R, et al. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke. 2014;45(10):3092–3096. doi:10.1161/STROKEAHA.114.00661725190438
  • Jullienne A, Obenaus A, Ichkova A, et al. Chronic cerebrovascular dysfunction after traumatic brain injury. J Neurosci Res. 2016;94(7):609–622. doi:10.1002/jnr.2373227117494
  • Guo ZY, Liu CX, Zhou R, et al. Discussion on factors related to the transformation of traumatic subdural effusion into chronic subdural hematoma. Ner Inj Func Reconstruc. 2016;11(2):122–124.
  • Wang Y, Chang H, Zou J, et al. The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray. Bio Pharma. 2011;65(2):118–122. doi:10.1016/j.biopha.2010.12.005
  • Wang D, Li T, Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers. J Neurol Sci. 2014;336(1–2):237–242. doi:10.1016/j.jns.2013.11.00524269089
  • Wang ZF, Liao DG. Role of matrix metalloproteinases in the transformation of subdural effusion into chronic subdural hematoma. J of Sout Medi Univ. 2010;30(5):1188–1189.
  • Wang YL, Hu SJ, Wang H, et al. Effects of different doses of rosuvastatin on serum high-sensitivity C-reactive protein and matrix metalloproteinase-9 in patients with acute coronary syndrome. Chi J Crit Care Med (Electronic Edition). 2014;7(3):195–198.
  • Ferretti G, Bacchetti T, Banach M, et al. Impact of statin therapy on plasma MMP-3, MMP-9, and TIMP-1 concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Angi. 2017;68(10):850–862. doi:10.1177/0003319716688301